Business Column: Pfizer doesn’t deserve any credit for ‘rolling back’ its price increases at Trump’s demand. Here’s why 12/07/2018 No comment Column: Pfizer doesn't deserve any credit for 'rolling back' its price increases at Trump's demand. Here's why https://t.co/8Oo79r5f4T pic.twitter.com/x6OsWuYW1w — Los Angeles Times (@latimes) July 12, 2018 Source: Twitter Share this:ShareEmailPrintTweetWhatsAppTelegramShare on Tumblr Related Tags: Post navigation Previous Previous post: US Marshals served subpoena on @FBI lawyer Lisa Page, Goodlatte says, threatening to hold her in contemptNext Next post: .@VP: “What the president focused on was a judicial philosophy. What he focused on was a body of work by Judge Kavanaugh.” Related Posts From @ReutersTV: Musk seeks support for Tesla buyout plan. See more By Robert Williams 13/08/2018 Internal company documents Facebook has fought hard to keep private could be made public in UK Parliament By Robert Williams 26/11/2018 #OPEC daily basket price stood at $61.14 a barrel Thursday, 23 November 2017 By Robert Williams 26/11/2017 You must log in to post a comment.This site uses Akismet to reduce spam. Learn how your comment data is processed.